A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

NCT04147806 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: IGRT 45 Gy in 5 fractions of 9 Gy
RADIATION: IGRT 24 Gy single dose
DRUG: Dexamethasone
DRUG: Tamsulosin

Sponsor

Albert Einstein College of Medicine